Anzeige
Mehr »
Login
Freitag, 08.11.2024 Börsentäglich über 12.000 News von 674 internationalen Medien
4.000 Meilen, um herauszufinden, warum der „Warren Buffett des Bergbaus" in diese Kupferaktie investierte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
470 Leser
Artikel bewerten:
(2)

Future Market Insights: Minimally Invasive Procedures Pump Up Electrophysiology Market to $9 Trillion by 2034

Finanznachrichten News

Future Market Insights, Inc. (FMI) predicts a vibrant future for the electrophysiology devices and equipment market, buoyed by surging demand for cardiac ablation procedures and continuous technological advancements. Explore the intricate dynamics of the growing market and discover valuable stakeholder opportunities in our detailed FMI report.

NEWARK, Del., Jan. 24, 2024 /PRNewswire/ -- The Electrophysiology Market value is expected to rise from US$ 4,350.7 billion in 2024 to US$ 9,078.4 billion by 2034. This estimated growth is expected to be driven by a CAGR of 7.60% over the next decade.

FMI_Logo

Request Exclusive Sample Report: Electrophysiology Industry Strategic Insights, https://www.futuremarketinsights.com/reports/sample/rep-gb-12402

The demand for cardiac ablation procedures is increasing across various geographies. Thus, spurring the adoption of electrophysiology devices and equipment. Certain common factors that drive market growth are increasing technological advancements in the field of electrophysiology and the rising prevalence of target diseases.

Advancements in electrophysiology have led to the development of enhanced devices that make procedures less invasive with improved atrial fibrillation treatment outcomes. Additionally, continuous technological upgrades in the applications of electrophysiology like cardiac magnetic resonance imaging (CMR), cardiac computerized tomography (CT), and electro-anatomic mapping, etc., are expected to accelerate product demand.

"Key players are focusing on innovation, advancement, and effectiveness of products to differentiate themselves and beat the market competition," says Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.).

Key Takeaways from the Electrophysiology Market Report

  • In North America, the markets in the United States and Canada are estimated to expand at CAGRs of 9.6% and 8.8% through 2034, respectively.
  • In Europe, Germany and France are predicted to rise at CAGRs of 9.9% and 8.7% through 2034, respectively.
  • The Indian electrophysiology market is projected to expand at a CAGR of 7.9% from 2024 to 2034.
  • EP ablation catheters are estimated to capture a market share of 42.1% in 2024.
  • Atrial fibrillation is the top indication segment that is assessed to occupy a share of 63.4% in 2024.
  • The hospital segment is projected to acquire a market share of 62.6% in 2024.

Competitive Landscape

Key players are expected to expand their operations in emerging countries over the forecast period. Additionally, companies are concentrating on providing remote monitoring tools, educational programs, and other support services to assist patients in managing their conditions and enhancing their quality of life. Leading players are further acquiring smaller players that have the latest technologies to increase their market access.

Industry leaders are utilizing online channels like search engine optimization, social media, and webinars to educate patients and physicians alike about the benefits of electrophysiology.

Key Electrophysiology Companies

  • Abbott Laboratories
  • Johnson & Johnson (Biosense Webster, Inc.)
  • Medtronic Plc
  • Boston Scientific Corporation
  • Japan Lifeline
  • Koninklijke Philips N.V.
  • Merit Medical Systems
  • Biotronik SE & Co. KG
  • Microport Scientific Corporation
  • APN Health, LLC
  • Baylis Medical Company, Inc.
  • Others

Purchase this report now to get key companies with their Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends, and Pricing Analysis.

Recent Developments in the Electrophysiology Market

  • In January 2024, CardioFocus, Inc., a medical device firm, acquired the Galvanize Therapeutics' Electrophysiology Technology division. In this acquisition, the notable assets include CENTAURI System pulsed electric field generator, which is available throughout the European Union and the United Kingdom. Another asset is QuickShot catheter ablation system, which is currently under development.
  • In August 2023, the use of cardiac electrophysiology (EP) services at Goa Medical College was approved by the state cabinet. Cardiac catheterization laboratory equipment will be used to treat patients and to train local cardiologists.
  • In January 2022, Abbott revealed that it had gained approval from the United States FDA for the EnSite X EP System equipped with EnSite Omnipolar Technology (OT). This new cardiac mapping platform is available across the United States and Europe and is designed to assist physicians in effectively treating abnormal heart rhythms, also called cardiac arrhythmias.

Key Segments in the Electrophysiology Market Report

By Product Type:

  • Electrophysiology Laboratory Devices
    • 3D Mapping Systems
    • Electrophysiology Recording Systems
    • Radiofrequency (RF) Ablation Systems
    • Intracardiac Echocardiography (Ice) Ultrasound Imaging Systems
    • Cardiac Stimulators
    • Others
  • Electrophysiology Ablation Catheters
    • Cryoablation Electrophysiology Catheters
    • Radiofrequency (RF) Ablation Catheters
    • Irrigated Tip RF Ablation Catheters
    • Laser Ablation Catheters
  • Electrophysiology Diagnostic Catheters
    • Conventional Electrophysiology Diagnostic Catheters
    • Advanced Electrophysiology Diagnostic Catheters
    • Ultrasound Electrophysiology Diagnostic Catheters
  • Access Devices

By Indication:

  • Atrial Fibrillation
  • Atrial Flutter
  • Wolff-Parkinson-White Syndrome (WPW)
  • Atrioventricular Nodal Reentry Tachycardia (AVNRT)
  • Ventricular tachycardia (VT)
  • Others

By End User:

  • Hospitals
  • Cardiac Catheterization Laboratories
  • Ambulatory Surgery Centers

By Region:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

Request to Access the Detail Research Methodology from here!

About the Author:

Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.

Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.

Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.

Explore FMI's Extensive Coverage in the Healthcare Domain:

  • Electrophysiology Equipment and Recording Systems Market: Global Industry Analysis and Opportunity Assessment 2022 - 2032. - Review and Request to Access the Sample PDF.
  • Intraoral Scanner Market Forecast by Open System and Closed System Modality for 2024 to 2034. - Review and Request to Access the Sample PDF.
  • Viscosupplementation Market Forecast by Knee Osteoarthritis, Hip Osteoarthritis, and Other Applications from 2024 To 2034. - Review and Request to Access the Sample PDF.
  • Autosampler Market Forecast by Autosampler Systems and Autosampler Accessories from 2024 to 2034. - Review and Request to Access the Sample PDF.
  • Cell Culture Media Market Forecast by Serum-free Media, CHO Media, and Others from 2024 to 2034. - Review and Request to Access the Sample PDF.

About Future Market Insights (FMI)

Future Market Insights (FMI) is a leading provider of market intelligence and consulting services, serving clients in over 150 countries. FMI is headquartered in Dubai, and has delivery centers in the UK, U.S. and India. FMI's latest market research reports and market analysis help businesses navigate challenges and make critical decisions with confidence and clarity amidst breakneck competition. Our customized and syndicated market research reports deliver actionable insights that drive sustainable growth. A team of expert led analysts at FMI continuously tracks emerging trends and events in a broad range of industries to ensure that our clients prepare for the evolving needs of their consumers.

Contact Us
Nandini Singh Sawlani
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware - 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube

Logo: https://mma.prnewswire.com/media/1197648/3531122/FMI_Logo.jpg

Cision View original content:https://www.prnewswire.co.uk/news-releases/minimally-invasive-procedures-pump-up-electrophysiology-market-to-9-trillion-by-2034-302043236.html

© 2024 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.